Small Molecule Injectable Drugs Market Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2028
Despite growth of biologic drugs, medicines based on small molecules
remain important in the treatment of all types of diseases such as oncology
disorders, infectious diseases, blood diseases, and cardiovascular diseases.
Market
Dynamics
Market players are initiating
production of injectable drugs in the new manufacturing facility, which is
expected to drive growth of the global small molecule injectable drugs, over
the forecast period. For instance, in August 2018, Pfizer Inc., a pharmaceutical
and Biotechnology Corporation, announced injectable production at Portage in
Kalamazoo, Michigan. The plant will enable Pfizer to produce injectable
medicines for patients suffering from chronic diseases such as oncology, across
the globe, as well as supporting the company’s supply capacity and production.
Comments
Post a Comment